See also this year's filing and all EDGAR filings for this company.
PDF Report 0001566373_2017_F_star_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001566373')"} |
Graph
Absolute values for 0001566373, F-star Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 25,570,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 522,000 |
| 3 | remainder_Assets | 787,000 |
| 4 | LiabilitiesCurrent | 3,501,000 |
| 5 | LiabilitiesNoncurrent | 27,000 |
| 6 | remainder_Liabilities | 6,333,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,739,000 |
| 9 | ResearchAndDevelopmentExpense | 14,017,000 |
| 10 | remainder_Expenses | -1,942,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 448,000 |
| 13 | remainder_ComprehensiveNetIncome | 11,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 26,879,000 |
| 1 | Liabilities | 9,861,000 |
| 2 | Expenses | 17,814,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 17,018,000 |
| 5 | NetIncome | -17,366,000 |
| 6 | ComprehensiveNetIncome | -17,360,500 |
| 7 | BaseVar | 27,506,500 |
| 8 | EconomicCapitalRatio | 0.648 |